SHZ · Financial Statements

Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393.SZ) Financial Statements

$12.51 SHZ: 002393.SZ Market Cap $4.19B

Full income statement, balance sheet, and cash flow statement for Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393.SZ), plus valuation and return ratios.

Annual financials are not yet available for this stock.

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA10.74
FCF Yield—
Quick Ratio4.36
Interest Coverage—
Return 1Y-29.34%
Return 3Y-8.87%
Return 5Y31.36%

Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393.SZ) financials — frequently asked questions

What is 002393.SZ EV/EBITDA?

Tianjin Lisheng Pharmaceutical Co.,Ltd.'s enterprise value to EBITDA (EV/EBITDA) ratio is 10.74.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
002393.SZ Overview 002393.SZ Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.